Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2025)

PROCEPT BioRobotics has reported Non-Current Assets over the past 6 years, most recently at $57.7 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $57.7 million for Q4 2025, up 10.6% from a year ago — trailing twelve months through Dec 2025 was $223.1 million (up 6.47% YoY), and the annual figure for FY2025 was $57.7 million, up 10.6%.
  • Non-Current Assets for Q4 2025 was $57.7 million at PROCEPT BioRobotics, up from $56.8 million in the prior quarter.
  • Over the last five years, Non-Current Assets for PRCT hit a ceiling of $57.7 million in Q4 2025 and a floor of $10.9 million in Q4 2021.
  • Median Non-Current Assets over the past 5 years was $51.7 million (2024), compared with a mean of $41.1 million.
  • Biggest five-year swings in Non-Current Assets: plummeted 30.95% in 2021 and later surged 238.25% in 2022.
  • PROCEPT BioRobotics' Non-Current Assets stood at $10.9 million in 2021, then surged by 238.25% to $36.7 million in 2022, then surged by 47.54% to $54.2 million in 2023, then dropped by 3.65% to $52.2 million in 2024, then grew by 10.6% to $57.7 million in 2025.
  • The last three reported values for Non-Current Assets were $57.7 million (Q4 2025), $56.8 million (Q3 2025), and $55.0 million (Q2 2025) per Business Quant data.